Updated May 2026
Rybelsus vs Wegovy Tablets
Side-by-side comparison of Rybelsus (semaglutide (oral)) and Wegovy Tablets (semaglutide HD-oral) across efficacy, food restrictions, monthly cost, and Medicare Bridge coverage.
Our pick for most patients
Wegovy Tablets
Based on the data below, Wegovy Tablets wins on covered under the Medicare GLP-1 Bridge ($50/mo from Jul 1, 2026). Your situation may differ — try the personalized matcher on the homepage or compute your real out-of-pocket with the cost calculator on each medication's detail page.
| Field | Rybelsus | Wegovy Tablets |
|---|---|---|
| Route | tablet · daily | tablet · daily |
| Avg weight loss | 8–10% | 12–15% |
| Food restriction | 30-min fast required | Empty stomach |
| Cash from | $998/mo | $149/mo |
| Savings card | — | — |
| Medicare Bridge | Tier 4 | $50/mo ✓ |
| A1c reduction | −1.4% | — |
| FDA approved | 2019-09 | 2025-12 |
- RouteRybelsustablet · dailyWegovy Tabletstablet · daily
- Avg weight lossRybelsus8–10%Wegovy Tablets12–15%
- Food restrictionRybelsus30-min fast requiredWegovy TabletsEmpty stomach
- Cash fromRybelsus$998/moWegovy Tablets$149/mo
- Savings cardRybelsus—Wegovy Tablets—
- Medicare BridgeRybelsusTier 4Wegovy Tablets$50/mo ✓
- A1c reductionRybelsus−1.4%Wegovy Tablets—
- FDA approvedRybelsus2019-09Wegovy Tablets2025-12
Pick Rybelsus if…
Pick Wegovy Tablets if…
- You're on Medicare and want the $50/mo Bridge price
- Cash pay matters more than peak weight loss ($149/mo cheaper)
- You want the higher peak efficacy (15% vs 10%)
Not sure which fits?
The 30-second matcher on the homepage scores every 2026 GLP-1 against your goals + preferences and recommends the best fit.